2024-04-012025-03-312025-03-31false14484590EXCHANGE CLINIC LTD2025-06-24falseiso4217:GBPxbrli:pure144845902024-04-01144845902025-03-31144845902024-04-012025-03-31144845902023-10-01144845902024-03-31144845902023-10-012024-03-3114484590bus:SmallEntities2024-04-012025-03-3114484590bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3114484590bus:FullAccounts2024-04-012025-03-3114484590bus:PrivateLimitedCompanyLtd2024-04-012025-03-3114484590core:WithinOneYear2025-03-3114484590core:AfterOneYear2025-03-3114484590core:WithinOneYear2024-03-3114484590core:AfterOneYear2024-03-3114484590core:ShareCapital2025-03-3114484590core:SharePremium2025-03-3114484590core:RevaluationReserve2025-03-3114484590core:OtherReservesSubtotal2025-03-3114484590core:RetainedEarningsAccumulatedLosses2025-03-3114484590core:ShareCapital2024-03-3114484590core:SharePremium2024-03-3114484590core:RevaluationReserve2024-03-3114484590core:OtherReservesSubtotal2024-03-3114484590core:RetainedEarningsAccumulatedLosses2024-03-3114484590core:LandBuildings2025-03-3114484590core:PlantMachinery2025-03-3114484590core:Vehicles2025-03-3114484590core:FurnitureFittings2025-03-3114484590core:OfficeEquipment2025-03-3114484590core:NetGoodwill2025-03-3114484590core:IntangibleAssetsOtherThanGoodwill2025-03-3114484590core:ListedExchangeTraded2025-03-3114484590core:UnlistedNon-exchangeTraded2025-03-3114484590core:LandBuildings2024-03-3114484590core:PlantMachinery2024-03-3114484590core:Vehicles2024-03-3114484590core:FurnitureFittings2024-03-3114484590core:OfficeEquipment2024-03-3114484590core:NetGoodwill2024-03-3114484590core:IntangibleAssetsOtherThanGoodwill2024-03-3114484590core:ListedExchangeTraded2024-03-3114484590core:UnlistedNon-exchangeTraded2024-03-3114484590core:LandBuildings2024-04-012025-03-3114484590core:PlantMachinery2024-04-012025-03-3114484590core:Vehicles2024-04-012025-03-3114484590core:FurnitureFittings2024-04-012025-03-3114484590core:OfficeEquipment2024-04-012025-03-3114484590core:NetGoodwill2024-04-012025-03-3114484590core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3114484590core:ListedExchangeTraded2024-04-012025-03-3114484590core:UnlistedNon-exchangeTraded2024-04-012025-03-3114484590core:MoreThanFiveYears2024-04-012025-03-3114484590core:Non-currentFinancialInstruments2025-03-3114484590core:Non-currentFinancialInstruments2024-03-3114484590dpl:CostSales2024-04-012025-03-3114484590dpl:DistributionCosts2024-04-012025-03-3114484590core:LandBuildings2024-04-012025-03-3114484590core:PlantMachinery2024-04-012025-03-3114484590core:Vehicles2024-04-012025-03-3114484590core:FurnitureFittings2024-04-012025-03-3114484590core:OfficeEquipment2024-04-012025-03-3114484590dpl:AdministrativeExpenses2024-04-012025-03-3114484590core:NetGoodwill2024-04-012025-03-3114484590core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3114484590dpl:GroupUndertakings2024-04-012025-03-3114484590dpl:ParticipatingInterests2024-04-012025-03-3114484590dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3114484590core:ListedExchangeTraded2024-04-012025-03-3114484590dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3114484590core:UnlistedNon-exchangeTraded2024-04-012025-03-3114484590dpl:CostSales2023-10-012024-03-3114484590dpl:DistributionCosts2023-10-012024-03-3114484590core:LandBuildings2023-10-012024-03-3114484590core:PlantMachinery2023-10-012024-03-3114484590core:Vehicles2023-10-012024-03-3114484590core:FurnitureFittings2023-10-012024-03-3114484590core:OfficeEquipment2023-10-012024-03-3114484590dpl:AdministrativeExpenses2023-10-012024-03-3114484590core:NetGoodwill2023-10-012024-03-3114484590core:IntangibleAssetsOtherThanGoodwill2023-10-012024-03-3114484590dpl:GroupUndertakings2023-10-012024-03-3114484590dpl:ParticipatingInterests2023-10-012024-03-3114484590dpl:GroupUndertakingscore:ListedExchangeTraded2023-10-012024-03-3114484590core:ListedExchangeTraded2023-10-012024-03-3114484590dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-10-012024-03-3114484590core:UnlistedNon-exchangeTraded2023-10-012024-03-3114484590core:NetGoodwill2025-03-3114484590core:IntangibleAssetsOtherThanGoodwill2025-03-3114484590core:LandBuildings2025-03-3114484590core:PlantMachinery2025-03-3114484590core:Vehicles2025-03-3114484590core:FurnitureFittings2025-03-3114484590core:OfficeEquipment2025-03-3114484590core:AfterOneYear2025-03-3114484590core:WithinOneYear2025-03-3114484590core:ListedExchangeTraded2025-03-3114484590core:UnlistedNon-exchangeTraded2025-03-3114484590core:ShareCapital2025-03-3114484590core:SharePremium2025-03-3114484590core:RevaluationReserve2025-03-3114484590core:OtherReservesSubtotal2025-03-3114484590core:RetainedEarningsAccumulatedLosses2025-03-3114484590core:NetGoodwill2024-03-3114484590core:IntangibleAssetsOtherThanGoodwill2024-03-3114484590core:LandBuildings2024-03-3114484590core:PlantMachinery2024-03-3114484590core:Vehicles2024-03-3114484590core:FurnitureFittings2024-03-3114484590core:OfficeEquipment2024-03-3114484590core:AfterOneYear2024-03-3114484590core:WithinOneYear2024-03-3114484590core:ListedExchangeTraded2024-03-3114484590core:UnlistedNon-exchangeTraded2024-03-3114484590core:ShareCapital2024-03-3114484590core:SharePremium2024-03-3114484590core:RevaluationReserve2024-03-3114484590core:OtherReservesSubtotal2024-03-3114484590core:RetainedEarningsAccumulatedLosses2024-03-3114484590core:NetGoodwill2023-10-0114484590core:IntangibleAssetsOtherThanGoodwill2023-10-0114484590core:LandBuildings2023-10-0114484590core:PlantMachinery2023-10-0114484590core:Vehicles2023-10-0114484590core:FurnitureFittings2023-10-0114484590core:OfficeEquipment2023-10-0114484590core:AfterOneYear2023-10-0114484590core:WithinOneYear2023-10-0114484590core:ListedExchangeTraded2023-10-0114484590core:UnlistedNon-exchangeTraded2023-10-0114484590core:ShareCapital2023-10-0114484590core:SharePremium2023-10-0114484590core:RevaluationReserve2023-10-0114484590core:OtherReservesSubtotal2023-10-0114484590core:RetainedEarningsAccumulatedLosses2023-10-0114484590core:AfterOneYear2024-04-012025-03-3114484590core:WithinOneYear2024-04-012025-03-3114484590core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3114484590core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3114484590core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3114484590core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3114484590core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3114484590core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3114484590core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3114484590core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3114484590core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3114484590core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3114484590core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3114484590core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3114484590core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3114484590core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3114484590core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3114484590core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3114484590core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3114484590core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3114484590core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3114484590core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3114484590core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3114484590core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3114484590core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3114484590core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3114484590core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3114484590core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3114484590core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3114484590bus:Director12024-04-012025-03-3114484590bus:Director22024-04-012025-03-31

EXCHANGE CLINIC LTD

Registered Number
14484590
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

EXCHANGE CLINIC LTD
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

EYRUMLU, Azad, Dr
SHAKIR, Honar

Company Secretary

EYRUMLU, Azad, Dr

Registered Address

74 Pentland Road
Slough
SL2 1TN

Registered Number

14484590 (England and Wales)
EXCHANGE CLINIC LTD
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets3327,669-
327,669-
Current assets
Debtors4559,9071
Cash at bank and on hand72,189-
632,0961
Creditors amounts falling due within one year5(404,460)-
Net current assets (liabilities)227,6361
Total assets less current liabilities555,3051
Creditors amounts falling due after one year6(143,453)-
Net assets411,8521
Capital and reserves
Called up share capital11
Profit and loss account411,851-
Shareholders' funds411,8521
The financial statements were approved and authorised for issue by the Board of Directors on 24 June 2025, and are signed on its behalf by:
EYRUMLU, Azad, Dr
Director
SHAKIR, Honar
Director

Registered Company No. 14484590
EXCHANGE CLINIC LTD
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Plant and machinery7
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
2.Average number of employees

20252024
Average number of employees during the year22
3.Tangible fixed assets

Plant & machinery

Total

££
Cost or valuation
Additions366,743366,743
At 31 March 25366,743366,743
Depreciation and impairment
Revaluation surplus39,07439,074
At 31 March 2539,07439,074
Net book value
At 31 March 25327,669327,669
At 31 March 24--
4.Debtors: amounts due within one year

2025

2024

££
Amounts owed by group undertakings559,906-
Other debtors11
Total559,9071
5.Creditors: amounts due within one year

2025

2024

££
Amounts owed to related parties357,664-
Finance lease and HP contracts46,796-
Total404,460-
6.Creditors: amounts due after one year

2025

2024

££
Other creditors143,453-
Total143,453-
7.Obligations under finance leases

2025

2024

££
Finance lease and HP contracts143,453-
8.Related party transactions
The intercompany balances consist entirely of related party transactions, which form part of the ultimate controlling party. The accumulated balance as at year end, owed to the company is £363,132.
9.Controlling party
The Ultimate controlling party is Saliv Limited.